Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.
Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 1, 2026 1 PM-2 PM ET
This presentation will explore the value of in-house CGP, offer insights into the benefits and drawbacks of incorporation, and provide information about important practical factors when considering in-house implementation of CGP.
Webinar presenter Allison M. Cushman-Vokoun, MD, PhD, FCAP, Medical Director, Molecular Diagnostics and Personalized Medicine Laboratory, Director, Division of Diagnostic Molecular Pathology and Human Genetics, Henry F. Krous Professor of Pathology, University of Nebraska Medical Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
September 2017—Singulex is developing an ultra-sensitive Clostridium difficile toxin A/B assay for use on its Sgx Clarity system, a fully automated, in vitro diagnostics platform powered by single-molecule counting technology.
September 2017—Instrumentation Laboratory launched its customized connectivity solution, GemWeb Plus 500. From its dashboard, GemWeb Plus 500 offers complete control of Gem Premier critical care testing systems, including Gem Premier 5000 with Intelligent Quality Management 2, as well as connectivity to non-IL-manufactured devices at the point of care. GemWeb Plus 500 is accessible from tablet devices, PCs, and any networked analyzer.
September 2017—Advanced Instruments displayed its newly launched Anoxomat III at the 69th AACC Annual Scientific Meeting and Clinical Lab Expo in San Diego.
September 2017—Dx-Sys has developed an ultra-sensitive, lateral flow point-of-care diagnostic test for glial fibrillary acidic protein, a potential biomarker for traumatic brain injury.
August 2017—MDxHealth has signed an exclusive licensing deal with Ghent University, Belgium, for its proprietary molecular diagnostic visualization technology that will allow the visual detection of epigenetic changes associated with cancer in tissue and liquid specimens.
August 2017—Myriad Genetics announced results from Study 005, a large 2,000 patient prospective study of the Myriad myRisk Hereditary Cancer test, which were featured in three poster presentations at the American Society of Clinical Oncology annual meeting in June.
August 2017—Quidel received 510(k) clearance to market its Solana C. difficile Assay for the direct, qualitative detection of Clostridium difficile DNA in unformed stool specimens of patients suspected of having Clostridium difficile infection.
August 2017—SeraCare Life Sciences launched iQ NGS QC Management v2, data management software that supports whole-workflow data capture from sample preparation to variant calling along with associated reagent and operator data. The software enables laboratories to re-create their QC workflows, set up their critical quality control metrics in the software, and have the data imported automatically using the new iQ Connector API—all to provide real-time insights into performance.
August 2017—GenomeDx Biosciences launched its Decipher Bladder Cancer Classifier following the publication of a study in European Urology (Seiler R, et al. Epub ahead of print April 5, 2017) supporting its development and validation. The company believes Decipher Bladder is the first commercially available clinical assay to subtype muscle-invasive bladder cancer with a high degree of accuracy.
August 2017—The Stago group has completed the acquisition of HemoSonics LLC, a company that develops point-of-care testing solutions and is based in Charlottesville, Va., with facilities in Durham, NC.
